D. E. Shaw & Co., Inc. Prime Medicine, Inc. Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 139,451 shares of PRME stock, worth $467,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139,451
Holding current value
$467,160
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.41 - $6.7 $320,594 - $629,907
94,016 Added 206.92%
139,451 $539,000
Q2 2024

Aug 14, 2024
BUY
$4.3 - $8.03 $80,698 - $150,699
18,767 Added 70.37%
45,435 $233,000
Q1 2024

May 15, 2024
BUY
$6.35 - $9.39 $169,341 - $250,412
26,668 New
26,668 $186,000

Others Institutions Holding PRME

# of Institutions
124
Shares Held
64.7M
Call Options Held
324K
Put Options Held
64.4K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email